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Response to Comment on ‘‘Screening for Abdominal
Aortic Aneurysm and Overall Mortality in Men’’
Dr. Koelemay must be acknowledged for his careful review
of the meta-analysis, which has revealed a citation error in
the manuscript, for which we apologise. The data used in
the original and revised long-term meta-analyses are not
from the preliminary 10-year report from the Viborg study
as cited,1 but from the complete 7-year report,2 as for the
MASS trial.3 If the preliminary 10-year results are used in
the long-term analysis, we agree that the upper 95% C.I.
limit for the odds ratio hits 1.00.
For interpretation, one has to remember the effect of
screening and the data used in the calculation of odds
ratios. The effect is a delay of death but in the end, we are
all going to die. Thus, the most relevant statistics to use are
survival analyses. However, this would require merging of
results from all the randomised trials. This has been
attempted but without success. Consequently, we can only
use meta-analysis to address this question. However,
calculation of the pooled odds ratio is based upon the
number of deaths in the invited group versus the control
group and ultimately the numbers will be equal in the two
groups, and the OR will become 1.00. The modified calcu-
lation seems just to be a manifestation of that progression.
The existing meta-analysis still shows that screening
reduces overall mortality, and the risk association would
probably have been even stronger if seven-year results
from the Chichester and Australian Studies had been
available instead of after 15 and 12 years, respectively.References
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Sir,
We were surprised by the publication of this systematic
review. However valuable, the topic and contents are the
sameaswas publishedearlier in the British Journal of Surgery
and the Cochrane Library.1,2 Publication of a Cochrane
systematic review also in a paper-based medical journal has
been accepted to enlarge the readership to those who have
limited access to the Cochrane Library.
Theauthorsof thepresentpaper includevirtually thesame
trials and reach a similar conclusion. They even refer to the
previous systematic review, but do not (and obviously cannot)
indicate what is new in their work. Although this may be
deductable to a juxtaposition of nearly simultaneous publi-
cations, it has led to redundancy in the surgical literature.
Although we understand the interest of editors of
medical journals to include systematic reviews as poten-
tially high-referenced sources of the state-of-the-art for
their readers, they should avoid even the semblance of
double publication. For this purpose, a section with
summaries of interesting work published in other journals
would be fair to the original authors. The Journal of
Vascular Surgery has done so, but without referring to the
original authors.3 Again, such a publication appears neither
original nor ethical.
In preparing their manuscript, authors should definewhat
is known and motivate what is new in what they want toDOI of original article: 10.1016/j.ejvs.2008.06.010.
